Match List I with List II:
|
LIST I (Microorganism) |
LIST II (Product Obtained) |
|
A. Trichoderma polysporum |
I. Ethanol |
|
B. Monascus purpureus |
II. Citric Acid |
|
C. Saccharomyces cerevisiae |
III. Cyclosporin A |
|
D. Aspergillus niger |
IV. Statins |
Choose the correct answer from the options given below:
Answer & explanation
Correct answer: option 4
The correct answer is Option (4) → A-III, B-IV, C-I, D-II
|
LIST I (Microorganism) |
LIST II (Product Obtained) |
|
A. Trichoderma polysporum |
III. Cyclosporin A |
|
B. Monascus purpureus |
IV. Statins |
|
C. Saccharomyces cerevisiae |
I. Ethanol |
|
D. Aspergillus niger |
II. Citric Acid |
A. Cyclosporin A is a bioactive molecule that is widely used as an immunosuppressive agent in organ transplant patients. It plays a crucial role in preventing organ rejection by suppressing the immune system's response to the transplanted organ. This important medication is derived from the fungus Trichoderma polysporum.
B. Statins produced by the yeast Monascus purpureus. Statins are a group of drugs that are used to lower cholesterol levels in the body.
C. Ethanol also known as ethyl alcohol, is commonly produced through the process of fermentation. Fermentation involves the conversion of sugars into alcohol and carbon dioxide by the action of microorganisms, typically yeast (Saccharomyces cerevisiae).
D. Aspergillus niger is a fungus known for its ability to produce citric acid. It is widely used in the food and beverage industry for the production of citric acid, which is commonly used as a flavoring agent and preservative.